Procurement Summary
Country : Brazil
Summary : Acquisition of Norfloxacino, Thypofiban, Valganciclovir and Others
Deadline : 18 Jun 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 120495242
Document Ref. No. : 90274/2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of norfloxacino, Tyofibana, Valganciclovir and others
UASG Code: 90181
Notice from: 06/06/2025 from 08:00 to 17:00 HS
Proposal Delivery: From 06/06/2025 to 08:00
norfloxacino, dosage 400 mg
quantity: 10
salbutamol, dosage 100mcg/dose, Pharmaceutical form aerosol oral
Quantity: 100
Tyofiban hydrochloride, dosage 0.25 mg/mL, pharmaceutical form injectable solution
Quantity: 50
valgancyclovir chloride, dosage 450 mg
quantity: 450
enailpril maleate, dosage 10 mg
quantity: 10000
sodium chloride, 0.9 %concentration, 0.9 %, ShapePharmaceutical Solution Injectable
Quantity: 165000
Budesonide, concentration 0.25mg/ ml, type Drug Type for nebulization
Quantity: 300
daptomycin, concentration 500 mg, pharmaceutical form liophilic powder
quantity: 200
ertapenem sodium, dosage 1 g, Injectable presentation
quantity: 70
Amino acids, Amino acid composition ASP, GLU, ALA, ARG, PHE, GLY, HIS, ILLE, LEU, Amino Acid Composition 1 LYS, MET, PRO, SER, TYR, THR, TRP, VAL, ADDITIONAL C/ GLC and Lipid Emulsion, Concentration 1 About 15% + 30% + 20%, Energy Content About 1000 Kcal, Pharmaceutical Form 1 EmulsionInjectable, additional characteristics 1 in triple camera bag
Quantity: 200
Isosorbid, active ingredient salt mononitrate, dosage 20 mg
quantity:12700
Documents
Tender Notice